|
ID2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.69300004518414E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.4925999991533E-08 |
| Normal-vs-Stage2 |
2.976100E-04 |
| Normal-vs-Stage3 |
1.955950E-04 |
| Normal-vs-Stage4 |
4.153400E-04 |
| Stage1-vs-Stage2 |
2.591600E-01 |
| Stage1-vs-Stage3 |
5.805800E-01 |
| Stage1-vs-Stage4 |
5.179600E-01 |
| Stage2-vs-Stage3 |
1.801600E-01 |
| Stage2-vs-Stage4 |
1.660430E-01 |
| Stage3-vs-Stage4 |
9.356400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89339999234761E-09 |
| Normal-vs-AfricanAmerican |
3.348200E-02 |
| Normal-vs-Asian |
3.166100E-02 |
| Caucasian-vs-AfricanAmerican |
9.640400E-02 |
| Caucasian-vs-Asian |
1.545800E-01 |
| AfricanAmerican-vs-Asian |
2.995600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.71880000016311E-07 |
| Normal-vs-Female |
3.35689998021138E-09 |
| Male-vs-Female |
4.664500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.588500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.80359999660362E-08 |
| Normal-vs-Age(61-80Yrs) |
1.40980000007396E-07 |
| Normal-vs-Age(81-100Yrs) |
1.903920E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.266400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.953800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.910000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.029800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.418400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.059600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.13580000000869E-05 |
| Normal-vs-Grade 2 |
2.5648039247983E-11 |
| Normal-vs-Grade 3 |
5.97780000000103E-05 |
| Normal-vs-Grade 4 |
7.835200E-03 |
| Grade 1-vs-Grade 2 |
9.418400E-01 |
| Grade 1-vs-Grade 3 |
1.791150E-01 |
| Grade 1-vs-Grade 4 |
1.401160E-01 |
| Grade 2-vs-Grade 3 |
1.157280E-03 |
| Grade 2-vs-Grade 4 |
4.984100E-03 |
| Grade 3-vs-Grade 4 |
6.976600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.76147985087027E-12 |
| Normal-vs-ccB subtype |
8.995200E-03 |
| ccA subtype-vs-ccB subtype |
1.63890000004496E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.22340000025179E-07 |
| Normal-vs-N1 |
5.201000E-01 |
| N0-vs-N1 |
1.337080E-03 |
|
|
